Journal
CELL CYCLE
Volume 7, Issue 24, Pages 3829-3839Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.7.24.7231
Keywords
angiogenesis; cancer; immune system; oxidative stress; stem cells
Categories
Funding
- American Diabetes Association
- American Heart Association (National)
- Bugher Foundation Award
- Janssen Neuroscience Award
- LEARN Foundation Award
- MI Life Sciences Challenge Award
- Nelson Foundation Award
- NIH NIEHS [P30 ES06639]
- NIH NINDS/NIA
Ask authors/readers for more resources
Given that cancer and related disorders affect a wide spectrum of the world's population, and in most cases are progressive in nature, it is essential that future care must overcome the present limitations of existing therapies in the absence of toxic side effects. Mammalian forkhead transcription factors of the O class (FoxOs) may fill this niche since these proteins are increasingly considered to represent unique cellular targets directed against human cancer in light of their pro-apoptotic effects and ability to lead to cell cycle arrest. Yet, FoxOs also can significantly affect normal cell survival and longevity, requiring new treatments for neoplastic growth to modulate novel pathways that integrate cell proliferation, metabolism, inflammation and survival. In this respect, members of the FoxO family are extremely compelling to consider since these transcription factors have emerged as versatile proteins that can control angiogenesis, stem cell proliferation, cell adhesion and autoimmune disease. Further elucidation of FoxO protein function during neoplastic growth should continue to lay the foundation for the successful translation of these transcription factors into novel and robust clinical therapies for cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available